176 related articles for article (PubMed ID: 16231170)
1. [Anticoagulation for secondary prevention: which drug in which situation?].
Weil J; Schunkert H
Internist (Berl); 2005 Dec; 46(12):1310-7. PubMed ID: 16231170
[TBL] [Abstract][Full Text] [Related]
2. [Anticoagulants and antiplatelet agents in pregnancy].
Tsakiris DA
Ther Umsch; 2005 Jan; 62(1):23-7. PubMed ID: 15702703
[TBL] [Abstract][Full Text] [Related]
3. Use of antiplatelet agents and anticoagulants for cardiovascular disease: current standards and best practices.
Faxon DP
Rev Cardiovasc Med; 2005; 6 Suppl 4():S3-14. PubMed ID: 17710074
[TBL] [Abstract][Full Text] [Related]
4. [Bridging: Perioperative management of chronic anticoagulation or antiplatelet therapy].
Nowak-Göttl U; Langer F; Limperger V; Mesters R; Trappe RU
Dtsch Med Wochenschr; 2014 Jun; 139(24):1301-6. PubMed ID: 24892468
[TBL] [Abstract][Full Text] [Related]
5. Non-Vitamin K Antagonist Oral Anticoagulants and Antiplatelet Therapy for Stroke Prevention in Patients With Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials.
Kumar S; Danik SB; Altman RK; Barrett CD; Lip GY; Chatterjee S; Roubin GS; Natale A; Danik JS
Cardiol Rev; 2016; 24(5):218-23. PubMed ID: 26274538
[TBL] [Abstract][Full Text] [Related]
6. Role of novel and emerging oral anticoagulants for secondary prevention of acute coronary syndromes.
Ganetsky VS; Hadley DE; Thomas TF
Pharmacotherapy; 2014 Jun; 34(6):590-604. PubMed ID: 24338703
[TBL] [Abstract][Full Text] [Related]
7. Antiplatelet intervention in acute coronary syndrome.
Arora RR; Rai F
Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648
[TBL] [Abstract][Full Text] [Related]
8. Improving long-term ACS management: is there a role for the new antiplatelets?
Cohen M
J Interv Cardiol; 2012 Oct; 25(5):425-32. PubMed ID: 22574644
[TBL] [Abstract][Full Text] [Related]
9. Antiplatelet agents.
Varon D; Spectre G
Hematology Am Soc Hematol Educ Program; 2009; ():267-72. PubMed ID: 20008209
[TBL] [Abstract][Full Text] [Related]
10. Impact of antiplatelet therapy in heart disease.
Renda G; de Caterina R
Adv Cardiol; 2012; 47():5-19. PubMed ID: 22906899
[TBL] [Abstract][Full Text] [Related]
11. Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial.
Stone GW; White HD; Ohman EM; Bertrand ME; Lincoff AM; McLaurin BT; Cox DA; Pocock SJ; Ware JH; Feit F; Colombo A; Manoukian SV; Lansky AJ; Mehran R; Moses JW;
Lancet; 2007 Mar; 369(9565):907-19. PubMed ID: 17368152
[TBL] [Abstract][Full Text] [Related]
12. [Update on the prevention of thromboembolic phenomena in atrial fibrillation].
Montagna M R; Asenjo G R; Morris C R; Ortiz O M; Cereceda B M
Rev Med Chil; 2007 Aug; 135(8):1048-55. PubMed ID: 17989864
[TBL] [Abstract][Full Text] [Related]
13. The Educational Needs of Clinicians Regarding Anticoagulation Therapy for Prevention of Thromboembolism and Stroke in Patients With Atrial Fibrillation.
Glauser TA; Barnes J; Nevins H; Cerenzia W
Am J Med Qual; 2016; 31(1):38-46. PubMed ID: 25115364
[TBL] [Abstract][Full Text] [Related]
14. Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the current status and what does the future hold?
Huber K; Bates ER; Valgimigli M; Wallentin L; Kristensen SD; Anderson JL; Lopez Sendon JL; Tubaro M; Granger CB; Bode C; Ohman EM; Steg PG
Am Heart J; 2014 Nov; 168(5):611-21. PubMed ID: 25440788
[TBL] [Abstract][Full Text] [Related]
15. Management of the antiplatelet therapy during the diagnosis of venous thromboembolism disease: A national survey of French general practitioners' compared to the French vascular physicians' management.
Fayol A; Plaisance L; Poenou G; Helfer H; Le Jeune S; Mahé I
J Med Vasc; 2020 May; 45(3):107-113. PubMed ID: 32402424
[TBL] [Abstract][Full Text] [Related]
16. Atherothrombotic disease and the role of antiplatelet therapy in women.
Grines C; Cho L
J Womens Health (Larchmt); 2008; 17(1):35-46. PubMed ID: 18240980
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) trial.
Jolly SS; Faxon DP; Fox KA; Afzal R; Boden WE; Widimsky P; Steg PG; Valentin V; Budaj A; Granger CB; Joyner CD; Chrolavicius S; Yusuf S; Mehta SR
J Am Coll Cardiol; 2009 Jul; 54(5):468-76. PubMed ID: 19628124
[TBL] [Abstract][Full Text] [Related]
18. Current update on glycoprotein IIb-IIIa and direct thrombin inhibition in percutaneous coronary intervention for non-ST elevation acute coronary syndromes: balancing bleeding risk and antiplatelet efficacy.
Kwa AT; Rogers JH
J Interv Cardiol; 2008 Apr; 21(2):107-17. PubMed ID: 18248357
[TBL] [Abstract][Full Text] [Related]
19. Update on aspirin in the treatment and prevention of cardiovascular disease.
Hennekens CH
Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
[TBL] [Abstract][Full Text] [Related]
20. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]